Technology | June 28, 2006

Line of ICDs Allow Doctors to Collect Information Remotely


The Concerto/Virtuoso line of implantable cardiac devices reportedly consists of cardiac rhythm disease management products that allow for automatic, wireless remote data transmission from a heart failure patient’s device to the doctor’s office.

By allowing doctors to collect patient information remotely, the devices reportedly have the potential to reduce the number of office visits needed to monitor the patient and alert the physician about dangerous trends that may occur in a patient’s heart function between examinations.

The system can provide an alert to the physician when a serious change in the patient’s condition (as defined by programmed device parameters, such as frequent episodes of atrial fibrillation that could lead to stroke or death) is detected. The remote CareAlerts may have the potential to contribute to treatment decisions before the patient’s condition worsens.

The new system will not eliminate, but is designed to reduce, the number of office visits for heart failure patients with the implantable therapies.

Related Content

News | Implantable Cardioverter Defibrillator (ICD)

August 18, 2022 — A first-in-human multicenter trial involving Mayo Clinic used a new ablation technique for patients ...

Home August 18, 2022
Home
News | Implantable Cardioverter Defibrillator (ICD)

July 21, 2022 — The global automated external defibrillators market size was valued at USD 717 million in 2021. It is ...

Home July 22, 2022
Home
News | Implantable Cardioverter Defibrillator (ICD)

June 10, 2022 — Setting a lower price to enter a competitive market with established brand leaders is a common ...

Home June 10, 2022
Home
News | Implantable Cardioverter Defibrillator (ICD)
May 2, 2022 – High-risk patients who need defibrillators to prevent cardiac arrest can experience fewer complications ...
Home May 02, 2022
Home
News | Implantable Cardioverter Defibrillator (ICD)
February 14, 2022 — Philips, a global leader in health technology, is supporting the American Heart Association’s multi ...
Home February 14, 2022
Home
Feature | Implantable Cardioverter Defibrillator (ICD) | By Dave Fornell, Editor

February 2, 2020 — The U.S. Food and Drug Administration (FDA) has identified a recent recall of the Boston Scientific ...

Home February 02, 2021
Home
News | Implantable Cardioverter Defibrillator (ICD)

January 8, 2020 — A new study published this week in HeartRhythm, the journal of the Heart Rhythm Society (HRS), found ...

Home January 08, 2021
Home
News | Implantable Cardioverter Defibrillator (ICD)

May 8, 2020 — Final results from the UNTOUCHED study of the Emblem Subcutaneous Implantable Defibrillator (S-ICD) System ...

Home May 08, 2020
Home
Feature | Implantable Cardioverter Defibrillator (ICD)

May 8, 2020 — A new clinical trial is the first to compare the safety and efficacy of subcutaneous implantable ...

Home May 08, 2020
Home
News | Implantable Cardioverter Defibrillator (ICD)

October 11, 2019 — Medtronic plc announced the start of a worldwide pivotal study evaluating its investigational ...

Home October 11, 2019
Home
Subscribe Now